Loading
FM
Foundation Medicine, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by ROCHE HOLDINGS INC, was filed 02 Aug 2018.
Foundation Medicine, Inc.: what insiders have been doing
Foundation Medicine, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). Foundation Medicine, Inc. has had no insider filing for more than a year; the last one goes back to 2 August 2018.
Over the whole record (from 2016), the tally stands at 2 purchases and 192 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
291
Thresholds
n/a
Buy Volume
€2B
2 ops. · all time
Sell Volume
€49M
192 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2017FY ended December 2017 · cache
Income statement
Revenue136.3M
Net income-143.9M-105.6% margin
Last declaration on 2 August 2018
Declarations291 total
13,877,949 shares@ US$137.0085.6% of flowCommon StockSEC:0000950103-18-009381:0
Canonical exit: 29 Oct 2018 (T+90)
2,343,078 shares@ US$137.0014.4% of flowCommon StockSEC:0000950103-18-009381:1
Canonical exit: 29 Oct 2018 (T+90)
103,711 shares@ US$137.0056.0% of flowCommon StockSEC:0001209191-18-044933:0
30,993 shares@ US$137.0020.4% of flowCommon StockSEC:0001209191-18-044931:0
36,186 shares@ US$137.0023.8% of flowCommon StockSEC:0001209191-18-044931:1
5,786 shares@ US$137.00100.0% of flowCommon StockSEC:0001209191-18-044937:0
15,955 shares@ US$137.0017.2% of flowCommon StockSEC:0001209191-18-044920:0
65,332 shares@ US$137.0070.3% of flowCommon StockSEC:0001209191-18-044920:1
35,221 shares@ US$137.0012.3% of flowCommon StockSEC:0001209191-18-044919:0
206,847 shares@ US$137.0072.4% of flowCommon StockSEC:0001209191-18-044919:1
76,494 shares@ US$137.0061.5% of flowCommon StockSEC:0001209191-18-044926:0
28,709 shares@ US$137.0023.1% of flowCommon StockSEC:0001209191-18-044926:1
6,955 shares@ US$137.005.8% of flowCommon StockSEC:0001209191-18-044936:0
42,215 shares@ US$137.0035.4% of flowCommon StockSEC:0001209191-18-044936:1
33,421 shares@ US$137.0067.4% of flowCommon StockSEC:0001209191-18-044917:0
3,253 shares@ US$137.008.7% of flowCommon StockSEC:0001209191-18-044924:0
23,582 shares@ US$137.0062.9% of flowCommon StockSEC:0001209191-18-044924:1
19,074 shares@ US$137.0024.7% of flowCommon StockSEC:0001209191-18-044932:0
46,937 shares@ US$137.0060.8% of flowCommon StockSEC:0001209191-18-044932:1
12,120 shares@ US$137.0048.9% of flowCommon StockSEC:0001209191-18-044922:0
12,669 shares@ US$137.0051.1% of flowCommon StockSEC:0001209191-18-044922:1
17,652 shares@ US$137.0058.0% of flowCommon StockSEC:0001209191-18-044928:0
9,300 shares@ US$137.0030.6% of flowCommon StockSEC:0001209191-18-044928:1
73,173 shares@ US$137.00100.0% of flowCommon StockSEC:0001209191-18-044916:0
2,675 shares@ US$136.662.9% of flowCommon StockSEC:0001209191-18-041544:0
25 of 291 declarations
About Foundation Medicine, Inc.
Foundation Medicine, Inc. is a company focused on developing genomic tests for cancer. It provides solutions that assist physicians in personalizing treatments for their patients.
